Cancer/Tumor Profiling Market Report

Japan Cancer/Tumor Profiling Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 14, 2019
  • PAGES：208
  • REPORT CODE：GMM229177
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Cancer/Tumor Profiling market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Cancer/Tumor Profiling market. Detailed analysis of key players, along with key growth strategies adopted by Cancer/Tumor Profiling industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • QIAGEN N.V. (Netherlands)

    • NeoGenomics Laboratories (U.S.)

    • HTG Molecular Diagnostic (U.S.)

    • Illumina Inc. (U.S.)

    • Genomic Health Inc. (U.S.)


    By Type:

    • Next-generation Sequencing

    • In Situ Hybridization

    • Immunohistochemistry

    • Quantitative PCR


    By End-User:

    • Personalized Medicine

    • Biomarker Discovery

    • Diagnostics

    • Prognostics


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer/Tumor Profiling Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Next-generation Sequencing from 2014 to 2026

      • 1.3.2 Japan Cancer/Tumor Profiling Market Size and Growth Rate of In Situ Hybridization from 2014 to 2026

      • 1.3.3 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Immunohistochemistry from 2014 to 2026

      • 1.3.4 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Quantitative PCR from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

      • 1.4.2 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Biomarker Discovery from 2014 to 2026

      • 1.4.3 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Diagnostics from 2014 to 2026

      • 1.4.4 Japan Cancer/Tumor Profiling Market Size and Growth Rate of Prognostics from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Cancer/Tumor Profiling Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer/Tumor Profiling by Major Types

      • 3.4.1 Market Size and Growth Rate of Next-generation Sequencing

      • 3.4.2 Market Size and Growth Rate of In Situ Hybridization

      • 3.4.3 Market Size and Growth Rate of Immunohistochemistry

      • 3.4.4 Market Size and Growth Rate of Quantitative PCR

    4 Segmentation of Cancer/Tumor Profiling Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer/Tumor Profiling by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cancer/Tumor Profiling in Personalized Medicine

      • 4.4.2 Market Size and Growth Rate of Cancer/Tumor Profiling in Biomarker Discovery

      • 4.4.3 Market Size and Growth Rate of Cancer/Tumor Profiling in Diagnostics

      • 4.4.4 Market Size and Growth Rate of Cancer/Tumor Profiling in Prognostics


    5 Market Analysis by Regions

    • 5.1 Japan Cancer/Tumor Profiling Production Analysis by Regions

    • 5.2 Japan Cancer/Tumor Profiling Consumption Analysis by Regions


    6 Hokkaido Cancer/Tumor Profiling Landscape Analysis

    • 6.1 Hokkaido Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 6.2 Hokkaido Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    7 Tohoku Cancer/Tumor Profiling Landscape Analysis

    • 7.1 Tohoku Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 7.2 Tohoku Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    8 Kanto Cancer/Tumor Profiling Landscape Analysis

    • 8.1 Kanto Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 8.2 Kanto Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    9 Chubu Cancer/Tumor Profiling Landscape Analysis

    • 9.1 Chubu Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 9.2 Chubu Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    10 Kinki Cancer/Tumor Profiling Landscape Analysis

    • 10.1 Kinki Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 10.2 Kinki Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    11 Chugoku Cancer/Tumor Profiling Landscape Analysis

    • 11.1 Chugoku Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 11.2 Chugoku Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    12 Shikoku Cancer/Tumor Profiling Landscape Analysis

    • 12.1 Shikoku Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 12.2 Shikoku Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    13 Kyushu Cancer/Tumor Profiling Landscape Analysis

    • 13.1 Kyushu Cancer/Tumor Profiling Landscape Analysis by Major Types

    • 13.2 Kyushu Cancer/Tumor Profiling Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 QIAGEN N.V. (Netherlands)

      • 14.1.1 QIAGEN N.V. (Netherlands) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 NeoGenomics Laboratories (U.S.)

      • 14.2.1 NeoGenomics Laboratories (U.S.) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 HTG Molecular Diagnostic (U.S.)

      • 14.3.1 HTG Molecular Diagnostic (U.S.) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Illumina Inc. (U.S.)

      • 14.4.1 Illumina Inc. (U.S.) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Genomic Health Inc. (U.S.)

      • 14.5.1 Genomic Health Inc. (U.S.) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 107 Figures and 139 Tables)

     

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Next-generation Sequencing from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of In Situ Hybridization from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Immunohistochemistry from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Quantitative PCR from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Biomarker Discovery from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Prognostics from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Cancer/Tumor Profiling Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cancer/Tumor Profiling Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cancer/Tumor Profiling

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer/Tumor Profiling by Different Types from 2014 to 2026

    • Table Consumption Share of Cancer/Tumor Profiling by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Next-generation Sequencing

    • Figure Market Size and Growth Rate of In Situ Hybridization

    • Figure Market Size and Growth Rate of Immunohistochemistry

    • Figure Market Size and Growth Rate of Quantitative PCR

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cancer/Tumor Profiling by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cancer/Tumor Profiling by Different End-Users from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Biomarker Discovery from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Figure Japan Cancer/Tumor Profiling Market Size and Growth Rate of Prognostics from 2014 to 2026

    • Table Japan Cancer/Tumor Profiling Production by Regions

    • Table Japan Cancer/Tumor Profiling Production Share by Regions

    • Figure Japan Cancer/Tumor Profiling Production Share by Regions in 2014

    • Figure Japan Cancer/Tumor Profiling Production Share by Regions in 2018

    • Figure Japan Cancer/Tumor Profiling Production Share by Regions in 2026

    • Table Japan Cancer/Tumor Profiling Consumption by Regions

    • Table Japan Cancer/Tumor Profiling Consumption Share by Regions

    • Figure Japan Cancer/Tumor Profiling Consumption Share by Regions in 2014

    • Figure Japan Cancer/Tumor Profiling Consumption Share by Regions in 2018

    • Figure Japan Cancer/Tumor Profiling Consumption Share by Regions in 2026

    • Table Hokkaido Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Hokkaido Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Hokkaido Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Hokkaido Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Tohoku Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Tohoku Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Tohoku Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Tohoku Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Tohoku Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Kanto Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Kanto Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Kanto Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Kanto Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Kanto Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Chubu Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Chubu Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Chubu Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Chubu Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Chubu Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Kinki Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Kinki Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Kinki Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Kinki Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Kinki Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Chugoku Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Chugoku Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Chugoku Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Chugoku Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Chugoku Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Shikoku Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Shikoku Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Shikoku Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Shikoku Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Shikoku Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Kyushu Cancer/Tumor Profiling Consumption by Types from 2014 to 2026

    • Table Kyushu Cancer/Tumor Profiling Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by Types in 2014

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by Types in 2018

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by Types in 2026

    • Table Kyushu Cancer/Tumor Profiling Consumption by End-Users from 2014 to 2026

    • Table Kyushu Cancer/Tumor Profiling Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by End-Users in 2014

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by End-Users in 2018

    • Figure Kyushu Cancer/Tumor Profiling Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of QIAGEN N.V. (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN N.V. (Netherlands)

    • Figure Sales and Growth Rate Analysis of QIAGEN N.V. (Netherlands)

    • Figure Revenue and Market Share Analysis of QIAGEN N.V. (Netherlands)

    • Table Product and Service Introduction of QIAGEN N.V. (Netherlands)

    • Table Company Profile and Development Status of NeoGenomics Laboratories (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NeoGenomics Laboratories (U.S.)

    • Figure Sales and Growth Rate Analysis of NeoGenomics Laboratories (U.S.)

    • Figure Revenue and Market Share Analysis of NeoGenomics Laboratories (U.S.)

    • Table Product and Service Introduction of NeoGenomics Laboratories (U.S.)

    • Table Company Profile and Development Status of HTG Molecular Diagnostic (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HTG Molecular Diagnostic (U.S.)

    • Figure Sales and Growth Rate Analysis of HTG Molecular Diagnostic (U.S.)

    • Figure Revenue and Market Share Analysis of HTG Molecular Diagnostic (U.S.)

    • Table Product and Service Introduction of HTG Molecular Diagnostic (U.S.)

    • Table Company Profile and Development Status of Illumina Inc. (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina Inc. (U.S.)

    • Figure Sales and Growth Rate Analysis of Illumina Inc. (U.S.)

    • Figure Revenue and Market Share Analysis of Illumina Inc. (U.S.)

    • Table Product and Service Introduction of Illumina Inc. (U.S.)

    • Table Company Profile and Development Status of Genomic Health Inc. (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health Inc. (U.S.)

    • Figure Sales and Growth Rate Analysis of Genomic Health Inc. (U.S.)

    • Figure Revenue and Market Share Analysis of Genomic Health Inc. (U.S.)

    • Table Product and Service Introduction of Genomic Health Inc. (U.S.)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US